INS and type 2 diabetes mellitus: These results suggest that the TCF7L2 locus may not only affect susceptibility to T2D, but may also modulate response to sulfonylurea therapy; in both cases, the pathophysiology likely stems from impaired insulin secretion due to deteriorating β-cell function.